The emerging popularity of novel psychoactive substances in the UK presents a serious risk to user safety. Often marketed online, these compounds frequently lack thorough testing and their impacts are poorly understood. Obtaining them carries a high chance of encountering unpredictable negative reactions, impurities, and potential judicial penaltie